Our Team
We bring together diverse expertise across science, technology, and innovation, united by a shared commitment to advancing breakthrough therapies and redefining what’s possible in cancer treatment.
-
Jim Song, Ph.D.
Co-Founder
Professor and Chair of Biochemistry and Molecular Biology, Associate Director for Basic Research at Feist-Weiller Cancer Center
-
Arum Han, Ph.D.
Co-Founder
Texas Instruments Professor, Associate Dean for Research, College of Engineering, Texas A&M University; Associate Agency Director, Texas A&M Engineering Experiment Station (TEES)
-
Song-I Han, Ph.D.
Co-Founder & CTO
Research Scientist, Texas A&M University
-
Chelsea Hu, Ph.D.
Co-Founder
Assistant Professor, Department of Chemical Engineering at Texas A&M University
-
Cassian Yee, M.D.
Co-Founder
Professor, Melanoma Medical Oncology Professor, Immunology Director, Solid Tumor Cell Therapy Co-Director, Adoptive Cellular Therapy Platform Scientific Director, Cell Therapy Manufacturing Facility MD Anderson Cancer Center
-
Paul de Figueiredo, Ph.D.
Co-Founder
NextGen Precision Health Endowed Professor, Department of Molecular Microbiology and Immunology, Department of Veterinary Pathobiology (courtesy), Bond Life Sciences Center, Member, University of Missouri